Streetbeat News

Stock Prices

JNJ

LLY

NVO

Novo Nordisk's diabetes drug, Ozempic, is gaining popularity for weight loss, potentially impacting companies providing weight-loss services like liposuction and bariatric surgeries. Johnson & Johnson reported a shortfall in its Q3 medical device sales due to a decrease in bariatric surgeries, which could be linked to the rise of Ozempic. Eli Lilly is preparing to release its own weight loss drug, Mounjaro, to compete with Ozempic and Wegovy.

Portfolio Pulse from Aaron Bry

October 27, 2023 | 7:15 pm

MMSI

Needham analyst Mike Matson has reiterated a Buy rating on Merit Medical Systems, Inc. (NASDAQ:MMSI) but lowered the price target from $96 to $81. Despite a solid Q3 2023 performance, the company is undergoing a turnaround after facing challenges with acquisitions and a declining operating margin. Matson expects revenue and EPS growth to improve, and management is implementing a plan to increase the operating margin and cash flow. The price target was lowered due to a downward revaluation of the company's peers.

Portfolio Pulse from Nabaparna Bhattacharya

October 27, 2023 | 7:10 pm

ALL

A significant bearish stance has been observed in Allstate's (NYSE:ALL) options activity, with 83% of investors opening trades with bearish expectations. The targeted price range for Allstate over the last 3 months is from $80.0 to $130.0. The price of ALL is currently down -1.99% at $123.12. Citigroup has maintained their Buy rating on Allstate, with a price target of $156.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:02 pm

WELL

Welltower (NYSE:WELL) is set to release its quarterly earnings report on October 30, 2023. Analysts estimate an earnings per share (EPS) of $0.89. The company's past performance shows a generally positive trend, with shares up 33.83% over the last 52-week period. Investors will be looking for not only an earnings beat but also positive guidance for the next quarter.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:02 pm

NOC

A significant investor has taken a bearish stance on Northrop Grumman (NYSE:NOC), with 61% of recent trades being bearish and 38% bullish. The targeted price range for the company over the last three months has been $440.0 to $490.0. The current price of NOC is down -0.94% at $473.29. UBS and Deutsche Bank have both downgraded their actions to Buy with price targets of $555 and $502 respectively.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:02 pm

JKS

JinkoSolar Holding Co (NYSE:JKS) is set to release its latest quarterly earnings report on October 30, 2023. Analysts estimate an earnings per share (EPS) of $1.44. The company's past performance shows a pattern of beating EPS estimates but experiencing a drop in share price. Over the last 52-week period, JinkoSolar's shares are down 45.55%.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:02 pm

RMBS

Rambus (NASDAQ:RMBS) is set to release its quarterly earnings report on October 30, 2023. Analysts estimate an earnings per share (EPS) of $0.41. The company's previous quarter saw a miss in EPS by $0.08, resulting in a 12.36% drop in share price. Over the last 52-week period, Rambus shares have increased by 69.61%.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:01 pm

CACC

Credit Acceptance (NASDAQ:CACC) is set to release its quarterly earnings report on October 30, 2023. Analysts estimate an EPS of $5.71. The company's past performance shows a pattern of share price drops following earnings beats. The stock is currently trading at $410.92, down 12.85% over the last 52 weeks.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:01 pm

OTTR

Otter Tail (NASDAQ:OTTR) is set to release its latest quarterly earnings report on October 30, 2023. Analysts estimate an earnings per share (EPS) of $1.62. The company's previous quarter saw an EPS beat by $0.50, resulting in a 9.59% increase in share price the next day. Shares of Otter Tail were trading at $71.15 as of October 26, with a 52-week increase of 4.78%.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:01 pm

NEXA

Nexa Res (NYSE:NEXA) is set to release its latest quarterly earnings report on October 30, 2023. Analysts estimate an earnings per share (EPS) of $-0.08. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $5.51, with a 52-week increase of 8.96%.

Portfolio Pulse from Benzinga Insights

October 27, 2023 | 7:01 pm